BridgeMD
New treatment option for Extracorporeal Membrane Oxygenation Complication
Official title Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO
ClinicalTrials.gov ID: NCT05698628
What this study is testing
- What it's testing
- Peripheral VA-ECMO is widely used in refractory cardiogenic shock patients as a salvage therapy. In most cases, the femoral artery and vein are used for the vascular approach.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age ≥19 years old
- Refractory cardiogenic shock with peripheral VA-ECMO
- Informed consent
You likely can't join if
- Unwilling or unable to obtain informed consent from the participant or substitute decision-maker
- Patients who are currently pregnant, postpartum period within 30 days or are breast-feeding
- VA-ECMO application for causes other than cardiogenic shock
- Severe coagulopathy
- Irreversible limb ischemia requiring treatment procedures or surgery at the time of VA-ECMO (previously diagnosed ASO(atherosclerosis obliterans)...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.